Financial Enhancement Group’s Boston Scientific BSX Stock Holding History

Financial Enhancement Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,520	Closed	-$290K	–	139
2026 Q1	$290K	Buy	4,520 +2	+0%	+$160	0.04%	127
2025 Q4	$414K	Buy	4,518 +24	+0.5%	+$2.35K	0.05%	115
2025 Q3	$435K	Sell	4,494 -8	-0.2%	-$828	0.06%	111
2025 Q2	$465K	Buy	4,502 +4	+0.1%	+$405	0.07%	106
2025 Q1	$428K	Buy	4,498 +12	+0.3%	+$1.21K	0.07%	99
2024 Q4	$424K	Buy	4,486 +38	+0.9%	+$3.35K	0.06%	100
2024 Q3	$239K	Sell	4,448 -37	-0.8%	-$2.92K	0.05%	111
2024 Q2	$337K	Buy	4,485 +22	+0.5%	+$1.61K	0.05%	101
2024 Q1	$304K	Buy	4,463 +15	+0.3%	+$964	0.05%	106
2023 Q4	$271K	Hold	4,448	–	–	0.05%	103
2023 Q3	$223K	Hold	4,448	–	–	0.04%	116
2023 Q2	$225K	Hold	4,448	–	–	0.04%	116
2023 Q1	$239K	Hold	4,448	–	–	0.05%	111
2022 Q4	$212K	Hold	4,448	–	–	0.04%	114
2022 Q3	$172K	Hold	4,448	–	–	0.04%	103
2022 Q2	$166K	Hold	4,448	–	–	0.04%	103
2022 Q1	$197K	Hold	4,448	–	–	0.04%	102
2021 Q4	$189K	Hold	4,448	–	–	0.03%	104
2021 Q3	$193K	Hold	4,448	–	–	0.04%	101
2021 Q2	$190K	Hold	4,448	–	–	0.04%	93
2021 Q1	$172K	Hold	4,448	–	–	0.04%	93
2020 Q4	$160K	Hold	4,448	–	–	0.03%	100
2020 Q3	$170K	Hold	4,448	–	–	0.04%	93
2020 Q2	$156K	Hold	4,448	–	–	0.04%	96
2020 Q1	$145K	Hold	4,448	–	–	0.04%	96
2019 Q4	$201K	Hold	4,448	–	–	0.05%	79
2019 Q3	$181K	Hold	4,448	–	–	0.05%	77
2019 Q2	$191K	Buy	+4,448	New	+$171K	0.06%	86

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Financial Enhancement Group's BSX Position: Q2 2026 in Review

Financial Enhancement Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,520 shares — an estimated $290K sold.

Financial Enhancement Group first reported a position in BSX in Q2 2019 and held it in 28 quarters. The position peaked at $465K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Financial Enhancement Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Financial Enhancement Group sold 4,520 Boston Scientific shares in Q2 2026, an estimated $290K.
Financial Enhancement Group first reported a position in Boston Scientific in Q2 2019 and held it in 28 quarters.
Financial Enhancement Group's Boston Scientific position peaked at $465K in Q2 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Financial Enhancement Group's 13F filing for Q2 2026, filed 7 Jul 2026.